Adams Kendra 4
4 · C4 Therapeutics, Inc. · Filed Sep 19, 2025
Insider Transaction Report
Form 4
Adams Kendra
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-09-18$3.32/sh−2,775$9,213→ 162,342 total - Exercise/Conversion
Common Stock
2025-09-18+6,250→ 165,117 total
Footnotes (2)
- [F1]Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on September 19, 2023.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.